๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

CD45-associated protein is not essential for the regulation of antigen receptor-mediated signal transduction

โœ Scribed by Chun Kung; Meinoshin Okumura; John R. Seavitt; Michelle E. Noll; Lynn S. White; Jeanette T. Pingel; Matthew L. Thomas


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
92 KB
Volume
29
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

โœฆ Synopsis


CD45 is a transmembrane protein tyrosine phosphatase required for signaling through the Tand B-cell antigen receptors. In lymphocytes, CD45 interacts with CD45-associated protein (CD45AP), a 32 000 Mr phosphoprotein, through their respective transmembrane domains. To determine whether CD45AP affects the ability of CD45 to regulate antigen receptor signaling, CD45AP-deficient mice were generated. Thymocyte development was grossly normal. Moreover, the cellularity of the thymus and spleens were normal. CD45 expression on thymocytes and splenocytes, ascertained by flow cytometry, was comparable between CD45AP-deficient mice and littermate controls. In contrast to a previous report (Matsuda et al., J. Exp. Med. 1998 187: 1863-1870). CD45AP-deficient and normal thymocytes and splenocytes proliferated similarly in response to various mitogens or antigen receptor crosslinking. Furthermore, thymocyte CD45-associated p56 lck kinase activity was similar between CD45AP-deficient and normal cells. We conclude that CD45AP is not essential for the regulation of Src-family kinase activity by CD45.


๐Ÿ“œ SIMILAR VOLUMES


Negative regulation of antigen receptor-
โœ Goutam Sen; Gabriel Bikah; Chandrasekar Venkataraman; Subbarao Bondada ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 172 KB ๐Ÿ‘ 3 views

CD5, a membrane-associated glycoprotein, has been shown to negatively regulate antigen receptor-mediated growth responses in peritoneal B lymphocytes, thymocytes and mature T cells. The CD5-expressing peritoneal B cells (B-1) that are normally unresponsive to B cell receptor (BCR)-mediated growth si